Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Novo Integrated Sciences Inc (NVOS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/06/2025: NVOS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $
1 Year Target Price $
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -89.18% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/06/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 0.08M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1 | 52 Weeks Range 0.00 - 0.80 | Updated Date 06/29/2025 |
52 Weeks Range 0.00 - 0.80 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.33 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -121.61% | Operating Margin (TTM) -30.39% |
Management Effectiveness
Return on Assets (TTM) -15.35% | Return on Equity (TTM) -82.47% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 3040806 | Price to Sales(TTM) 0.01 |
Enterprise Value 3040806 | Price to Sales(TTM) 0.01 | ||
Enterprise Value to Revenue 0.23 | Enterprise Value to EBITDA -1.58 | Shares Outstanding 19730200 | Shares Floating 18430616 |
Shares Outstanding 19730200 | Shares Floating 18430616 | ||
Percent Insiders 6.59 | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Novo Integrated Sciences Inc
Company Overview
History and Background
Novo Integrated Sciences Inc. (NVOS) was founded in 1983 as Fortrust Corporation. The company has evolved through various acquisitions and restructurings, focusing on healthcare solutions and technology-driven services.
Core Business Areas
- Medical and Rehabilitation Clinics: This segment provides healthcare services related to medical treatments and rehabilitation through clinics.
- Technology Development: This segment focuses on the development of technology solutions for healthcare applications.
Leadership and Structure
The leadership team includes Robert Mattacchione as CEO and a board of directors. The organizational structure comprises operational departments responsible for different business segments.
Top Products and Market Share
Key Offerings
- Medical Services: Provides a range of medical services including rehabilitation, pain management, and wellness programs. Market share data is difficult to obtain due to fragmentation. Competitors include other clinics and healthcare providers.
- Technology Solutions: Developing and integrating healthcare-related technologies. Market share is not publicly available. Competitors include other healthcare technology companies.
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth due to aging populations, technological advancements, and increasing demand for healthcare services.
Positioning
Novo Integrated Sciences Inc. is positioned as a provider of integrated healthcare solutions, focusing on both traditional medical services and technology-driven innovations.
Total Addressable Market (TAM)
The TAM for integrated healthcare solutions is substantial, potentially in the billions of dollars. NVOS's position depends on its ability to scale and innovate.
Upturn SWOT Analysis
Strengths
- Integrated Healthcare Approach
- Technology Development Capabilities
- Experienced Leadership
Weaknesses
- Limited Market Share
- Financial Instability
- Dependence on Key Personnel
- History of restructuring and dilution
Opportunities
- Expansion into New Markets
- Partnerships with Healthcare Providers
- Adoption of New Technologies
Threats
- Regulatory Changes
- Competition from Larger Healthcare Providers
- Economic Downturn
Competitors and Market Share
Key Competitors
- OTLY
- HIMS
- TDOC
Competitive Landscape
Novo Integrated Sciences Inc. faces competition from larger, more established healthcare providers and technology companies. Its advantage lies in its integrated approach, but it must overcome its limitations in market share and financial resources.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends require analysis of financial data over the past years. This is left as a placeholder that requires financial data.
Future Projections: Future growth projections depend on analyst estimates and market conditions. This is left as a placeholder that requires analyst data.
Recent Initiatives: Recent initiatives include strategic partnerships, technology development, and market expansion efforts.
Summary
Novo Integrated Sciences Inc. operates in the growing healthcare industry focusing on integrated solutions. It has faced financial challenges and operates with a small market share and continues to restructure. The company can gain ground through strategic initiatives and market expansion with continued investment into technology. Regulatory changes and competition pose ongoing challenges, demanding vigilance.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Market Research Reports
- Analyst Estimates
- Company Website
Disclaimers:
The data and analysis provided are based on publicly available information and are for informational purposes only. The analysis should not be construed as investment advice. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Novo Integrated Sciences Inc
Exchange NASDAQ | Headquaters Bellevue, WA, United States | ||
IPO Launch date 2017-09-22 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 115 | Website https://www.novointegrated.com |
Full time employees 115 | Website https://www.novointegrated.com | ||
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health programs, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning programs, including event and game coverage, and private personal training services through clinics. It also provides assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services through long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement homes and community, and long-term care sectors. Further, it provides medical technology platforms, such as Novo Connect, telemedicine/telehealth, and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company was formerly known as Turbine Truck Engines, Inc. and changed its name to Nova Integrated Sciences, Inc. in July 2017. The company is headquartered in Bellevue, Washington.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.